Expression of prolactin and prolactin receptor in human breast carcinoma. Evidence for an autocrine/paracrine loop
about
Characterization of Δ7/11, a functional prolactin-binding proteinXenoestrogens at picomolar to nanomolar concentrations trigger membrane estrogen receptor-alpha-mediated Ca2+ fluxes and prolactin release in GH3/B6 pituitary tumor cellsPhosphorylation of tyrosine 285 of PAK1 facilitates βPIX/GIT1 binding and adhesion turnoverCrystal Structure of an Affinity-matured Prolactin Complexed to Its Dimerized Receptor Reveals the Topology of Hormone Binding Site 2Growth hormone receptor is expressed in human breast cancerExpression of prolactin receptors in normal, benign, and malignant breast tissue: an immunohistological studyJanus kinase 2 is required for the initiation but not maintenance of prolactin-induced mammary cancerA comprehensive analysis of common genetic variation in prolactin (PRL) and PRL receptor (PRLR) genes in relation to plasma prolactin levels and breast cancer risk: the multiethnic cohort.Breastfeeding in relation to risk of different breast cancer characteristics.Minireview: Tipping the balance: ligand-independent activation of steroid receptors.The Pit-1/Pou1f1 transcription factor regulates and correlates with prolactin expression in human breast cell lines and tumorsStoichiometric structure-function analysis of the prolactin receptor signaling domain by receptor chimeras.Establishing a relationship between prolactin and altered fatty acid β-oxidation via carnitine palmitoyl transferase 1 in breast cancer cells.The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation.Cyclophilin B as a co-regulator of prolactin-induced gene expression and function in breast cancer cells.Prolactin receptor-integrin cross-talk mediated by SIRPα in breast cancer cells.Expression of prolactin receptors in normal canine mammary tissue, canine mammary adenomas and mammary adenocarcinomas.Development of a prolactin receptor-targeting fusion toxin using a prolactin antagonist and a recombinant form of Pseudomonas exotoxin A.Bioactive prolactin levels and risk of breast cancer: a nested case-control study.The role of prolactin in mammary carcinoma.Adapter protein SH2B1beta binds filamin A to regulate prolactin-dependent cytoskeletal reorganization and cell motility.Cannabinoids and cancer: pros and cons of an antitumour strategy.Roles and regulation of stat family transcription factors in human breast cancer.Immunoassay and Nb2 lymphoma bioassay prolactin levels and mammographic density in premenopausal and postmenopausal women the Nurses' Health Studies.Genetic variation in PRL and PRLR, and relationships with serum prolactin levels and breast cancer risk: results from a population-based case-control study in PolandThe two faces of Janus kinases and their respective STATs in mammary gland development and cancerEndocrine control of canine mammary neoplasms: serum reproductive hormone levels and tissue expression of steroid hormone, prolactin and growth hormone receptors.Prolactin receptor expression in the developing human prostate and in hyperplastic, dysplastic, and neoplastic lesionsAutocrine prolactin: an emerging market for homegrown (prolactin) despite the imports.Retinoic acid modulates prolactin receptor expression and prolactin-induced STAT-5 activation in breast cancer cells in vitro.Phase II study of RC-160 (vapreotide), an octapeptide analogue of somatostatin, in the treatment of metastatic breast cancer.Tyrosyl phosphorylated PAK1 regulates breast cancer cell motility in response to prolactin through filamin ASuppressor of cytokine signalling gene expression is elevated in breast carcinomaProlactin acts as a potent survival factor for human breast cancer cell lines.PAK1 regulates breast cancer cell invasion through secretion of matrix metalloproteinases in response to prolactin and three-dimensional collagen IV.Lipopolysaccharide induces the expression of an autocrine prolactin loop enhancing inflammatory response in monocytes.Regulation of prolactin receptor levels and activity in breast cancerExpression of cyclophilin B is associated with malignant progression and regulation of genes implicated in the pathogenesis of breast cancer.Insensitivity of human prolactin receptors to nonhuman prolactins: relevance for experimental modeling of prolactin receptor-expressing human cells.Impaired turnover of prolactin receptor contributes to transformation of human breast cells.
P2860
Q24300561-45557608-1513-4E61-88D1-3F16E772F452Q24814754-BD584017-CBA9-4A02-B4A3-BF7C91F2DCF3Q27319440-010BE8FD-47D9-4830-B796-485EA24C3FEBQ27646645-6C4B16C6-E7A8-4F78-818D-4CA06D110BC5Q28362049-2D404113-EF5A-4410-BE5D-B4B257CF1F0EQ28365602-8860BEBA-5370-41E0-9799-8A1FA7857138Q28588240-4CE668A1-248C-42D0-89AA-316D5ED47919Q33308309-4D7226F3-73FE-4616-A39B-8A14A6D92462Q33617363-CF4AC2C8-50EA-471D-A939-E6963EB2216AQ33631775-0BE45AF8-581C-46F1-A293-A6E22B467669Q33689207-78FB0C27-C448-4975-9CCB-CBBAF8FC986CQ33771375-194E15B5-01A8-44B0-ADE6-DAEC40439757Q33812119-09DE3B53-0906-49A3-A840-8C706B38A6B4Q34066911-85675766-35F2-4C59-8D3F-42F6BBF771C6Q34249025-FB716809-DE2F-44D6-9059-2D9E2B95580BQ34279935-773C5AD1-51F7-4531-A24B-60F64CFC9950Q34286753-5487EC19-63D3-4351-8314-D228FAAB0FF5Q34442075-D1EB7025-2317-405F-9748-839F115BE739Q34964061-9E7116E8-9440-4E71-91D5-0EFE4759CF60Q35067253-47303CB7-F7A4-4C10-A5BA-A643921C2BB3Q35073608-7D07707D-C739-41B0-8F36-05F58E042995Q35100892-500FC274-0EF8-4958-AD9F-F5A0406F431FQ35103357-7BC243D1-E6E9-4078-995C-EBAC26006EF2Q35238005-C26BC2FB-08F5-485D-8F60-EF1B22F5B187Q35559023-A0C1CFB6-3D72-461A-A553-8423DF141BB0Q35685851-A2C768AE-EBC2-4021-93CC-CF2AD9371159Q35775363-5E204A3E-6EFF-4677-8E4D-342EF8D8367BQ35786210-C961B260-E935-456E-ABED-17A14CBD0C5AQ36331355-B16FB627-0BAE-4618-9628-38A6C41E5441Q36617359-96BAF355-880F-4025-9577-D59FF1E4AECDQ36619058-2B8E9D8D-15CC-4D23-BF4C-54BD6AB6C4F9Q36660604-EE5675D7-CA65-4557-BED8-68A70C57BD65Q36671376-FE656B41-5862-4B67-8EE5-78988A4E540EQ36695290-90069C3E-C252-4A37-AED1-F8921D662B1CQ36998060-5654BB1D-F97C-4428-8D77-1DFA14147A5AQ37027615-8D694640-FFE5-4E94-BB04-39B2307CAD1DQ37060370-E8ABCB3F-0512-4BD4-B8E2-DBE305FD08C5Q37073826-11BBF1A8-5391-4310-8960-7EE4770BDCC7Q37136912-005DB25D-CA9A-4A78-9331-867059106289Q37149031-B5317B0A-8D1C-4B53-8DEE-FE669CBE4923
P2860
Expression of prolactin and prolactin receptor in human breast carcinoma. Evidence for an autocrine/paracrine loop
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Expression of prolactin and pr ...... or an autocrine/paracrine loop
@ast
Expression of prolactin and pr ...... or an autocrine/paracrine loop
@en
type
label
Expression of prolactin and pr ...... or an autocrine/paracrine loop
@ast
Expression of prolactin and pr ...... or an autocrine/paracrine loop
@en
prefLabel
Expression of prolactin and pr ...... or an autocrine/paracrine loop
@ast
Expression of prolactin and pr ...... or an autocrine/paracrine loop
@en
P2093
P2860
P1476
Expression of prolactin and pr ...... or an autocrine/paracrine loop
@en
P2093
C V Clevenger
J E Tomaszewski
K T Montone
P2860
P304
P407
P577
1995-03-01T00:00:00Z